Novabridge Biosciences (NBP) SEC Filings — 2024

Filings

• I-Mab Files Investor Presentation on Dec 3, 2024 — 6-K · Dec 3, 2024
• I-Mab Files Q3 2024 Financial Results — 6-K · Nov 14, 2024
• I-Mab Appoints Dr. Sean Fu as Permanent CEO — 6-K · Nov 6, 2024
• I-Mab Wins Jury Verdict in Trade Secret Misappropriation Case — 6-K · Nov 5, 2024
• I-Mab Files Q3 2024 Investor Presentation — 6-K · Oct 24, 2024
• I-Mab Director Resigns, New Director Appointed — 6-K · Sep 23, 2024
• I-Mab Presents Updated Givastomig Data at ESMO 2024 — 6-K · Sep 16, 2024
• I-Mab Enters Secondment Agreement with ABio-X Holdings — 6-K · Aug 30, 2024
• I-Mab Files Mid-Year 2024 Financial Update — 6-K · Aug 28, 2024
• I-Mab Changes Auditors from PwC China to PwC US — 6-K · Aug 7, 2024
• I-Mab Announces New CFO — 6-K · Jul 15, 2024
• I-Mab Files 6-K with Investor Presentation and Press Release — 6-K · Jun 6, 2024